News & Updates
Filter by Specialty:
Resmetirom demos potential in NASH
Safety analysis of the phase III MAESTRO-NAFLD-1 trial presented at ILC 2022 demonstrated the potential of resmetirom as a treatment for patients with non-alcoholic steatohepatitis (NASH) who have liver fibrosis.
Resmetirom demos potential in NASH
18 Jul 2022
Serum CTRP4 tied to coronary artery disease in T2DM
In patients with type 2 diabetes mellitus (T2DM), higher serum levels of circulating C1q tumour necrosis factor-related protein 4 (CTRP4) appear to aggravate the likelihood of coronary artery disease, a recent study has found.
Serum CTRP4 tied to coronary artery disease in T2DM
17 Jul 2022
Family history plus obesity/hyperglycaemia redoubles renal cell cancer risk
The interaction between genetic and environmental factors, specifically obesity and hyperglycaemia, contributes to an increased risk of renal cell cancer (RCC), suggests a study.
Family history plus obesity/hyperglycaemia redoubles renal cell cancer risk
16 Jul 2022
Keto or Mediterranean diet for diabetes: Do we have a clear winner?
The ketogenic (keto) diet appears as good as the Mediterranean diet in reducing blood sugar in individuals with prediabetes, or type 2 diabetes (T2D), according to a small, randomized, crossover trial.
Keto or Mediterranean diet for diabetes: Do we have a clear winner?
13 Jul 2022
More than 6 in 10 hospitalized diabetics have obstructive sleep apnoea
Obstructive sleep apnoea syndrome (OSAS) is common among hospitalized patients with type 2 diabetes mellitus (T2DM), afflicting over 60 percent of this patient population, a recent China study has found.